Home  »  Industry   »  Anheuser-Busch InBev SA/NV (NYSE:BUD): An Opportun...

Anheuser-Busch InBev SA/NV (NYSE:BUD): An Opportunity for Fundamental Investors?

Anheuser-Busch InBev SA/NV (NYSE:BUD) shares fell to a low of $73.58 before closing at $74.35. Intraday shares traded counted 1.43 million, which was 6.58% higher than its 30-day average trading volume of 1.53M. BUD’s previous close was $74.88 while the outstanding shares total 1.68B. The firm has a beta of 1.55, a 12-month trailing P/E ratio of 63.93, and a growth ratio of 26.64. The stock’s Relative Strength Index (RSI) is 68.83, with weekly volatility at 1.35% and ATR at 1.37. The BUD stock’s 52-week price range has touched low of $37.93 and a $75.77 high. The stock traded lower over the last trading session, losing -0.71% on 05/11/21.

Investors have identified the Beverages – Brewers company Anheuser-Busch InBev SA/NV as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $125.10 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.

Having a look at the company’s valuation, the company is expected to record 3.56 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on BUD sounds very interesting.

Is the stock of BUD attractive?

In the last 6 months, insiders have changed their ownership in shares of company stock by 53.90%.

15 out of 32 analysts covering the stock have rated it a Buy, while 13 have maintained a Hold recommendation on Anheuser-Busch InBev SA/NV. 1 analysts has assigned a Sell rating on the BUD stock. The 12-month mean consensus price target for the company’s shares has been set at $74.21.

Leave a Comment

Your email address will not be published. Required fields are marked *